Jeff Hall

The artificial intelligence (AI)-powered Ezra Flash reportedly enhances magnetic resonance imaging (MRI) and enables significant reductions in scan times and costs for full-body MRI.

In a large retrospective study involving over 523,000 digital breast tomosynthesis (DBT) exams and over one million digital mammography (DM) exams, researchers found that DBT was associated with significantly lower recall rates but showed no advantage over DM in the diagnosis of interval or advanced breast cancer.

Precision DL, a deep learning-based software which will be available on GE HealthCare’s Omni Legend PET/CT device, reportedly increases the detectability of small, low-contrast lesions by 42 percent.

Reportedly the first FDA-approved PSMA PET agent with proprietary radiohybrid technology, POSLUMA can be utilized for positron emission tomography (PET) scans of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer and suspected metastasis, and those with suspected prostate cancer recurrence based on an elevated serum prostate-specific antigen (PSA) level.

Photon-counting computed tomography (PCCT) significantly increased the signal-to-noise ratio (SNR) and the contrast-to-noise ratio (CNR) in comparison to dual-source CT (DSCT) at similar radiation dosing, according to a new study of over 100 children with suspected congenital heart defects.

In a study involving over 1,100 women diagnosed with breast cancer, researchers found that 48.7 percent of women alive or dead from other causes at a median follow-up of 11.7 years had moderately dense breasts. They also found that 46 percent of women who died from breast cancer at a median-follow-up of 5.3 years had moderately dense breasts.

Conditional use of full-body magnetic resonance imaging (MRI) is reportedly permitted for patients using any of the models for the remede® System, an implantable nerve stimulation therapy indicated for the treatment of adults with moderate to severe central sleep apnea.

In a multinational, multicenter study of over 1,000 patients with recurrent prostate cancer, researchers developed and validated a nomogram that achieved a 72 percent concordance index for the prediction of biochemical recurrence after PSMA PET-guided salvage radiotherapy.

Emerging breast ultrasound research showed the use of computer-aided diagnosis (CAD), powered by deep learning, led to 24 percent and 36.9 percent improvements in accuracy and specificity, respectively, in the use of BI-RADS classifications by radiologists without breast ultrasound expertise.

Six reader studies on digital mammography revealed a pooled sensitivity rate of 80.8 percent for stand-alone artificial intelligence (AI) in comparison to 72.4 percent for radiologist assessment while seven historic cohort studies showed a 75.8 percent pooled sensitivity rate for stand-alone AI versus 72.6 percent for radiologist interpretation of digital mammography.

In what may be the first comparative study of the polygenic risk score and the computed tomography (CT)-derived coronary artery calcium (CAC) score for assessing coronary heart disease (CHD) risk, researchers found that the CAC score was associated with significant improvements in assessing and stratifying risk for the development of CHD in middle-aged to older adults.

In a subgroup analysis of patients with intracerebral hemorrhage who had intraventicular hemorrhage (IVH) growth, researchers found that hypodensities on non-contrast computed tomography (CT) were associated with more than double the risk for greater than 1 mL of expanded IVH (eIVH).

In a recently published review, radiology researchers from the University of Wisconsin discussed the potential and key considerations for applying accelerated magnetic resonance imaging (MRI) protocols in the assessment of emergent and urgent conditions.

Through artificial intelligence (AI), Neurophet AQUA reportedly provides segmentation and analysis of brain magnetic resonance imaging (MRI) for possible brain atrophy in five minutes.

African American and Asian-Chinese women have a disproportionately higher prevalence of fibroids, according to newly published transvaginal ultrasound findings in a diverse population of nearly 1,000 women.

Unvaccinated people with COVID-19 who undergo angiographic reperfusion after acute ischemic stroke may have a greater than fivefold risk of continued infarct growth in comparison to unvaccinated people without COVID-19, according to computed tomography perfusion (CTP) and magnetic resonance imaging (MRI) findings from a recently published study.

The artificial intelligence (AI)-enabled CT 3500 system reportedly reduces patient positioning time by 23 percent, improves low-contrast detectability by 60 percent and facilitates up to an 80 percent reduction in radiation dosing.

In a recent interview, Rajesh Bhayana, M.D., shared insights from new research that compared the abilities of ChatGPT-3.5 and ChatGPT-4 to answer text-based questions akin to those found on a radiology board examination.

Updates to Contour ProtegeAI 4.0 reportedly include enhanced algorithms for radiation oncology segmentation and molecular radiotherapy.

In a recent video interview, David Ouyang, M.D., shared insights from two recent studies he co-authored on the use of artificial intelligence (AI) to improve initial assessment of left ventricular ejection fraction (LVEF) on echocardiography and ascertain cardiac risks associated with changes in the left ventricle sphericity index seen on magnetic resonance imaging (MRI).

In a large retrospective study of 26,455 participants from the National Lung Screening Trial, low dose computed tomography (LDCT) exams revealed significant incidental findings (SIFs), ranging from emphysema to suspicious lesions, in 8,954 participants.

The United States Preventive Services Task Force (USPSTF) has drawn praise for lowering the age threshold for initial mammography screening from 50 to 40 years of age in updated draft recommendations for breast cancer screening, but critics warn that biennial screening is not sufficient for higher-risk populations.

The DRX-Rise Mobile X-ray System reportedly combines optimal image quality with enhanced maneuverability and ease of use for radiologists.

After five months of exposure to repeated blast events, the majority of nine otherwise healthy military instructors had significantly increased amyloid deposition in the brain, according to positron emission tomography (PET) findings from a new study.

Adjunctive use of an artificial intelligence (AI) software demonstrated nearly equivalent sensitivity and over 28 percent higher accuracy in comparison to radiologist assessment of breast ultrasound images for breast lesions, according to new research presented at the recent Society of Breast Imaging (SBI) conference.

In a study involving 201 consecutive patients presenting to emergency departments (EDs) with abdominal pain, researchers found that radiology faculty accuracy rates in interpreting non-contrast, abdominopelvic computed tomography (CT) scans ranged from 68 to 74 percent.

While calling for a universal breast cancer risk assessment by the age of 25, the American College of Radiology (ACR) emphasized that ascertaining screening needs prior to the age of 40 is particularly important in high-risk populations such as Black women, who are 42 percent more likely to die from breast cancer in comparison to non-Hispanic White women.

The use of adjunctive artificial intelligence (AI) reportedly improved lesion level sensitivity by nearly 19 percent and patient level specificity by 14 percent for the diagnosis of clinically significant prostate cancer on multiparametric magnetic resonance imaging (MRI).

Regardless of experience level, radiologists are likely to be affected by automation bias when utilizing adjunctive artificial intelligence (AI) for mammography interpretation, according to newly published research.

In a recent video interview from the American Urological Association (AUA) 2023 Annual Meeting, Brian Helfand, M.D., discussed emerging research that shows the potential viability of the agent F18-rhPSMA-7.3 for enhancing the detection of prostate cancer recurrence and facilitating earlier intervention for patients with low prostate-specific antigen (PSA) levels.